Medicine and Dentistry
Human Immunodeficiency Virus
100%
Cohort Analysis
100%
Highly Active Antiretroviral Therapy
100%
Cancer Survival
100%
HIV/AIDS
100%
Cancer
70%
Malignant Neoplasm
40%
Overall Survival
10%
Retrospective Cohort Study
10%
Immunosuppressive Treatment
10%
Nasopharynx Carcinoma
10%
Human Immunodeficiency Virus Infection
10%
Nursing and Health Professions
Cohort Analysis
100%
Human Immunodeficiency Virus
100%
Highly Active Antiretroviral Therapy
100%
Cancer Survival
100%
Malignant Neoplasm
36%
Rate Ratio
18%
Independent Practice Association
9%
Overall Survival
9%
Human Immunodeficiency Virus Infection
9%
Nasopharynx Carcinoma
9%
Immunosuppressive Treatment
9%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
HIV
100%
Cancer Survival
100%
Malignant Neoplasm
36%
Nasopharynx Carcinoma
9%
Overall Survival
9%
Human Immunodeficiency Virus Infection
9%
Immunology and Microbiology
Human Immunodeficiency Virus
100%
HIV/AIDS
100%
Cancer Survival
100%
Immunosuppression
10%
Overall Survival
10%
Human Immunodeficiency Virus Infection
10%